May 22 (Reuters) - Ironwood Pharmaceuticals Inc said on Monday it would acquire Switzerland-based drug developer VectivBio Holding AG in a deal valued at about $1 billion, including debt. (Reporting by Raghav Mahobe in Bengaluru; Editing by Janane Venkatraman)
1st Jan change | Capi. | |
---|---|---|
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |